Obesity. Overweight and obesity
Conditions
Interventions
Intervention 1: Intervention group 1: Daily intermittent fasting (16:8, from 19 to 11 h)
these volunteers will also receive daily supplementation with whey and casein proteins, calcium, and vitamin D (the amounts will be determined by a nutritional specialist based on the daily needs of e
Sponsors
INTERNATIONAL SCIENCE AND TECHNOLOGY UNIVERSITY
Eligibility
Sex/Gender
Female
Age
50 Years to 65 Years
Inclusion criteria
Inclusion criteria: Female Age > 50 years Body mass index > 30 kg/m2 > 3 years after the final period Not engaged in regular exercise activities over the last six months No smoking or alcohol consumption
Exclusion criteria
Exclusion criteria: Suffering from chronic cardiovascular, liver and kidney diseases Having any pain or mobility limitations that prevent interventions. Current treatment with medication or supplements that significantly affect the main study variables. Having a history of bariatric surgery Following a special diet, including strict vegetarian/vegan, within the past 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Muscle mass. Timepoint: At baseline, and after 2-, 4-, and 6-month intervention as well as following 6-month follow-up. Method of measurement: By Dual-Energy X-ray Absorptiometry (DXA).;Bone mineral density. Timepoint: At baseline, and after 2-, 4-, and 6-month intervention as well as following 6-month follow-up. Method of measurement: By Dual-Energy X-ray Absorptiometry (DXA). | — |
Secondary
| Measure | Time frame |
|---|---|
| Body weight. Timepoint: At baseline, and after 2-, 4-, and 6-month intervention as well as following 6-month follow-up. Method of measurement: By digital scale.;Body fat, visceral adipose tissue. Timepoint: At baseline, and after 2-, 4-, and 6-month intervention as well as following 6-month follow-up. Method of measurement: By Dual-Energy X-ray Absorptiometry (DXA).;Muscle strength. Timepoint: At baseline, and after 2-, 4-, and 6-month intervention as well as following 6-month follow-up. Method of measurement: Using one repetition maximum test and digital strength measuring devices.;Balance. Timepoint: At baseline, and after 2-, 4-, and 6-month intervention as well as following 6-month follow-up. Method of measurement: Using the dynamic balance test.;Resting metabolic rate. Timepoint: At baseline, and after 2-, 4-, and 6-month intervention as well as following 6-month follow-up. Method of measurement: Indirect calorimetry.;Cognitive function. Timepoint: At baseline, and after 2-, 4-, and 6-month intervention as well as following 6-month follow-up. Method of measurement: Using functional tests to assess executive function, memory, processing speed, and attention.;Mood. Timepoint: At baseline, and after 2-, 4-, and 6-month intervention as well as following 6-month follow-up. Method of measurement: Using the Menopause-Specific Quality of Life Questionnaire, Patient Health Questionnaire-9, and Generalized Anxiety Disorder-7 questionnaire.;Plasma levels of irisin. Timepoint: At baseline, and after 2-, 4-, and 6-month intervention as well as following 6-month follow-up. Method of measurement: Using ELISA method.;Insulin resistance. Timepoint: At baseline, and after 2-, 4-, and 6-month intervention as well as following 6-month follow-up. Method of measurement: Using fasting glucose, HOMA-IR, and HbA1c measurements.;Lipid profile. Timepoint: At baseline, and after 2-, 4-, and 6-month intervention as well as following 6-month follow-up. Method of measurement: Using chole | — |
Countries
Turkey
Contacts
Public ContactDavar Khodadadi
Islamic Azad University
Outcome results
None listed